EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:145425 - EC 2.7.11.21 (polo kinase) inhibitor
| ChEBI ID | CHEBI:145425 |
| ChEBI Name | EC 2.7.11.21 (polo kinase) inhibitor |
| Stars | |
| Definition | An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of any polo kinase (EC 2.7.11.21). |
| Last Modified | 25 July 2024 |
| Submitter | Adnan |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) is a EC 2.7.11.* (protein-serine/threonine kinase) inhibitor (CHEBI:76812) |
| Incoming Relation(s) |
| BI-2536 (CHEBI:49868) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| GSK461364 (CHEBI:91333) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| GW843682X (CHEBI:91334) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| HMN-214 (CHEBI:91440) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| LFM-A13 (CHEBI:183517) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| rigosertib (CHEBI:145417) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| rigosertib sodium (CHEBI:145421) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| volasertib (CHEBI:231358) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| Synonyms | Source |
|---|---|
| EC 2.7.11.21 inhibitor | ChEBI |
| EC 2.7.11.21 (polo kinase) inhibitors | ChEBI |
| Cdc5p inhibitors | ChEBI |
| PLK inhibitors | ChEBI |
| Plk1 inhibitors | ChEBI |
| EC 2.7.11.21 inhibitors | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Polo_kinase | Wikipedia |